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Carbon monoxide, a classical respiratory 
inhibitor, also exerts vasodilatory, anti-
inflammatory and anti-apoptotic effects. CO-
releasing molecules (CO-RMs) have therapeutic 
value, increasing phagocytosis and reducing 
sepsis-induced lethality. Here we identify for 
the first time the bacterial targets of CORM-3, 
Ru(CO)3Cl(glycinate), a ruthenium-based 
carbonyl that liberates CO rapidly under 
physiological conditions. Contrary to the 
expectation that CO would be preferentially 
inhibitory at low oxygen tensions or 
anaerobically, Escherichia coli cultures were 
also sensitive to CORM-3 at concentrations 
equimolar with oxygen. CORM-3, assayed as 
Ru, was taken up by bacteria and rapidly 
delivered CO intracellularly to terminal 
oxidases. Microarray analysis of CORM-3-
treated cells revealed extensively modified gene 
expression, notably down-regulation of genes 
encoding key aerobic respiratory complexes. 
Genes involved in metal metabolism, 
homeostasis or transport, were also 
differentially expressed and free intracellular 
zinc levels were elevated. Probabilistic 
modelling of transcriptomic data identified the 
global transcription regulators ArcA, CRP, Fis, 
FNR, Fur, BaeR, CpxR and IHF as targets and 
potential CO sensors. Our discovery that 
CORM-3 is an effective inhibitor and global 
regulator of gene expression, especially under 
aerobic conditions, has important implications 
for administration of CO-releasing agents in 
sepsis and inflammation. 
 
 It has been recognised for over 80 years 
that carbon monoxide (CO) combines with ferrous 
hemoglobin, competing with oxygen and 
inhibiting respiration (1). Latterly, however, CO 
has been shown to have unexpected and profound 
physiological effects in higher organisms. 
Inducible heme oxygenase-1 (HO-1) and 
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constitutive heme oxygenase-2 (HO-2) degrade 
heme to generate CO that has vasodilatory, 
antiflammatory and anti-apoptotic effects (2). The 
CO is thought to target transition elements in 
biological systems, particularly hemes (in 
oxidases, globins and CO sensors, for example) 
(3), nickel (in CO dehydrogenase) and complex 
Ni-, Fe- and S-containing clusters (2). The impact 
of CO in physiology and medicine has prompted 
development of metal carbonyl compounds 
(carbon monoxide-releasing molecules, CO-RMs) 
to deliver CO in biological environments. Such 
molecules are pharmacologically active, eliciting 
vasodilation in isolated aorta and mediating 
hypotension in vivo (4). Newer water-soluble CO-
RMs have revealed roles for CO in suppression of 
inflammation, protection against hypoxia-
reoxygenation and oxidative stress and in 
mitigation of myocardial infarction and other 
disorders (5). 
 Considering the potent biological 
activities of CO and CO-RMs, we know little 
about CO toxicity towards microorganisms, 
despite CO being a stable gas that might find 
application in antimicrobial therapies. Indeed, 
recent studies in inflammatory models of disease, 
such as endotoxin exposure, suggest that HO-1 
and its products exert beneficial effects in mice (6-
8). Although biliverdin (9) generated by HO 
activity and CO significantly suppress the 
inflammatory response (10), it is now clear that 
HO-1-derived CO plays an important role in the 
antimicrobial process without inhibiting the 
inflammatory response (11). HO-deficient mice 
suffered exaggerated lethality from polymicrobial 
sepsis, whereas HO-1 over-expression improved 
survival from Enterococcus faecalis-induced 
sepsis (11). Direct evidence for CO involvement 
came from injection of CORM-2 
(tricarbonyldichlororuthenium (II) dimer 
[Ru(CO)3Cl2]2) into wild-type mice, which 
increased phagocytosis and rescued HO-1-
deficient mice from sepsis-induced lethality. CO-
RM-derived CO also inhibits bacterial growth and 
viability in vitro (12). The effectiveness of 
CORM-2 and CORM-3 was greater in near-
anaerobic environments, suggesting competitive 
inhibition of oxygen utilisation, but no link 
between the established hemoprotein reactivity of 
CO and the antibacterial activity of CO-RMs has 
been demonstrated. 
Exploiting the antimicrobial utility of CO 
and CO-RMs requires an understanding of the 
growth inhibitory effects and elucidation of the 
stress responses elicited. Here, we demonstrate 
that CORM-3 possesses potent antimicrobial 
activity against E. coli, particularly aerobically and 
that, in such cells, the compound is internalised 
and delivers CO to terminal oxidases. Moreover, 
the growth-inhibitory effects correlate with the 
results of a transcriptomic study and application of 
a probabilistic systems model, which reveal for the 
first time that bacteria mount a global response to 
CORM-3 involving aerobically eight transcription 
factors. We anticipate that understanding the 
molecular and biochemical mechanisms of CO 
delivery and toxicity, and the cognate bacterial 
stress responses, will contribute towards utilisation 




 E. coli strains and growth conditions - All 
strains used were E. coli K-12 derivatives: the 
wild-type was MG1655. Strains carrying lacZ 
transcriptional fusions were  ECL933 [Φ(cyo-lac) 
bla+ cyo+] (13), MC4100 λRS88 [spy-lacZ] (14) 
and RKP2910 [Φ(zntA-lacZ)] (15). The cyo 
mutant was RKP4544 (cyo::kan; laboratory 
collection). Cells were grown in defined media 
with glycerol (54 mM) as sole carbon source, as 
before (16). For anaerobic growth, fumarate was 
added as terminal electron acceptor (50 mM), in 
addition to LB (5% v/v) and casamino acids (0.1% 
w/v) to give a growth rate comparable to aerobic 
cultures. For aerobic growth, cells were grown in 
30 ml defined medium in 250 ml baffled flasks 
fitted with side-arms for measurements of optical 
density with a Klett meter (red filter) during 
shaking at 200 rpm and 37oC. Anaerobic growth 
was in Klett-compatible 8.5 ml screw-cap tubes, 
filled to the brim with defined medium, at 37oC in 
a water bath. For viability assays, anaerobic cells 
were grown in 175 ml batch cultures in defined 
medium in stirred (200 rpm) mini-fermenter 
vessels (17) modified for anoxic sampling by 
sparging with N2. Starter cultures were grown in 
defined media (anaerobic) or 10 ml LB (aerobic); 
for the latter, cells were harvested and resuspended 
3 
 
in defined medium before inoculation. Viability 
was determined after dilution of samples in water 
by plating 10 µl drops on nutrient agar. Protein 
concentrations were measured using the Markwell 
assay (18). 
 CORM-3 and CO treatments - CORM-3 
(Hemocorm) was prepared as a 100 mM stock 
solution in distilled water freshly for each 
experiment. RuCl2(DMSO)4 was prepared 
similarly. CO-saturated solutions were made by 
bubbling CO gas (CP grade) from a cylinder 
(BOC, Guildford, GU2 5XY) through buffer for 
20 min, resulting in a 1.8 mM stock solution. 
CORM-3, RuCl2(DMSO)4 and CO-saturated 
solution were added directly to growing cultures in 
log phase, determined by a Klett OD of ~40 (when 
grown in side-arm flasks or screw cap tubes) or an 
OD600 of ~ 0.5 (when grown in mini-fermenter 
vessels). 
Uptake of CORM-3 by growing cells - CORM-3 
was added during logarithmic phase to aerobic 
(final concentration 30 µM) and anaerobic (final 
concentration 100 µM) cultures. After 15 min, 
cells were harvested by centrifugation at 5000 g 
for 5 min (Sigma 4K15) in polypropylene tubes 
(Sarstedt 62.547.004 (50 ml) or 62.554.001 (15 
ml)).  Culture supernatants were retained for 
analysis.  Cell pellets were washed thrice in 0.5 % 
HNO3 (0.5 ml, Aristar nitric acid, 69 % v/v) to 
remove loosely bound elements.  Supernatants 
collected from the washes were also retained for 
analysis. Pellets were resuspended in HNO3 (0.5 
ml 69%) and placed in an ultrasonic bath for 30 
min to break the cells.  The resultant digest was 
then quantitatively transferred to a calibrated 15 
ml tube and made up to 5 ml with 1% HNO3.  
Samples were analysed using a Spectro CirosCCD 
(Spectro Analytical) inductively coupled plasma-
atomic emission spectrometer (ICP-AES) using 
background correction.  Calibration curves were 
created for each element to be tested using multi-
element standard solutions containing 0.1, 0.2, 1, 5 
and 10 mg L-1.  The wavelengths (nm) for 
elements reported here were Zn (213.856) and Ru 
(240.272).  A 1% nitric acid solution in MilliQ 
water was used as a blank and to dilute cell digests 
before ICP-AES analysis. Elemental recoveries 
were calculated from these samples.  
Calculation of dry cell weight and intracellular 
ruthenium concentrations – Dry weight was 
determined by filtering known volumes of culture 
(usually 10 ml, 20 ml and 30 ml) through pre-
weighed cellulose nitrate filters, 47 mm diameter 
and pore size 0.2 µm (Millipore).  The filters had 
previously been dried at 105 oC for 18-24 h to 
constant weight.  Filters were again dried at 105 
oC until a constant weight was attained, which was 
recorded. Alternatively, bacteria were sedimented 
in pre-weighed, dried centrifuge tubes, which were 
reweighed after drying to constant weight. Both 
methods gave similar results. To calculate 
intracellular Ru concentrations, we adopted 
published values for individual cell dry mass and 
volume (19). Values in Table 1 are means of two 
growth experiments, with each sample being 
assayed in triplicate by ICP-AES. 
 Cytochrome and respiration assays - 
Difference spectra (CO plus reduced minus 
reduced) of whole cells were recorded in a dual-
wavelength spectrophotometer (20). Cells were 
reduced with dithionite; after treatment with 
CORM-3, CO or RuCl2(DMSO)4, spectra were 
recorded in triplicate (10 mm path length) and 
averaged. For myoglobin competition analysis, 8 
µM CORM-3 was added to cells or buffer with 
dithionite. Myoglobin (10 µM) was added at 0, 10 
and 20 min and spectra recorded using a baseline 
of either reduced cells and myoglobin, or reduced 
buffer. The contribution of cytochrome o to CO 
difference spectra was determined by a 
deconvolution method. From the CO difference 
spectrum (mean of 3 scans) of cyo::kan cells was 
subtracted the spectrum of purified cytochrome bd 
(21), such that the distinctive signals in the red 
region (575-675 nm) were brought to zero. The 
resultant residual and the cytochrome bd spectrum 
were then subtracted from a scan of wild-type 
cells, leaving only the cytochrome bo' spectrum. 
 Samples were taken from  cultures after 
exposure to CORM-3, and the harvested cells 
washed and resuspended in 50 mM Tris buffer (pH 
7.5); respiration was measured using a Clark-type 
polarographic oxygen electrode (Rank Bros) at 
37oC (22). 
 β-galactosidase assays – Assays were 
carried out as described before (23) in CHCl3- and 
sodium dodecyl sulfate-permeabilised cells by 
monitoring o-nitrophenyl-β−D-galactopyranoside 
hydrolysis. Activities are expressed in terms of the 
OD600 of cell suspensions using the formula of 
Miller (23). Each suspension was assayed in 
triplicate and results were confirmed in at least 
two independent experiments. For assays of 
Φ(zntA-lacZ) activity (15), we included where 
shown 0.5 mM Zn(II) to elevate the low basal 
levels of expression, as described in (24). 
 Microarray Analysis - Cells were grown 
aerobically in 30 ml defined medium in 250 ml 
baffled side arm flasks or anaerobically in 
fermenter vessels as above. At log phase (Klett 
OD~40 or OD600~ 0.5), CORM-3 (30 µM for 
aerobic cells, 100 µM for anaerobic cells) was 
added and, after 15 min, 30 ml culture was added 
to chilled phenol (188 µl)/ethanol (3.6 ml), and 
flash-frozen in liquid nitrogen. RNA was prepared 
using an RNeasy Minikit from Qiagen, from four 
biological repeats of control and CORM-3 
exposed cells. Other procedures were as described 
before (16,17). The data have been deposited in 
NCBI's Gene Expression Omnibus and are 




 Modelling transcription factor activities - 
Transcriptomic data were analysed using a 
probabilistic model (26), which adopts a log-linear 
approximation to the transcriptional reaction to 
changes in transcription factor activity. Changes in 
gene expression as a weighted linear combination 
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Here,  is the log-fold change for the n-th gene, 
 a binary matrix encoding the structure of the 
regulatory network (obtained from the literature), 
 the unknown rate constants for activation/ 
repression,  the (log) change in transcription 





nε  an error term. Both the rate 
constants and the transcription factor activity 
changes are given zero mean normal priors. 
Standard statistical inference techniques provide 
estimates of the changes in activity of regulators 
from an analysis of the behaviour of their targets. 
This technique has been applied to reconstructing 
the regulatory response in E. coli to the transition 
between aerobic and microaerobic conditions (27). 
 
RESULTS 
 CORM-3, but not a solution of CO gas, 
targets both aerobically and anaerobically 
growing E. coli - To establish conditions for CO-
RM toxicity, we first defined the growth inhibitory 
effects of CORM-3, a proprietary water-soluble 
CO-RM (28). We first tested CORM-3 against an 
anaerobic culture with glycerol as carbon source 
and fumarate as terminal electron acceptor, 
expecting the absence of oxygen, with which CO 
competes, to reveal maximal CORM-3 toxicity. 
Addition of 100 µM CORM-3 slowed growth but 
higher concentrations (200 µM) were required to 
inhibit growth completely (Supplementary Fig. 
S1A). However, under these aerobic conditions 
(Supplementary Fig. S1B), CORM-3 at only 30 
µM inhibited growth and 100 µM CORM-3 totally 
prevented further growth. Inoculation of cells into 
media containing 250 µM CORM-3 also 
prevented growth and killed a significant 
proportion of cells within 2 h (not shown). 
However, the same concentrations of CO added as 
a CO-saturated solution did not prevent anaerobic 
or aerobic growth, nor did RuCl2(DMSO)4, a 
compound with similar structure to CORM-3 but 
where the carbonyl groups have been replaced 
with DMSO (28) (Supplementary Fig. S1A and B, 
insets). 
 The toxicity of CORM-3 was also 
investigated by measuring cell viability under our 
growth conditions. Anaerobically, 100 µM 
CORM-3 had no effect on viable counts within 2 h 
(Supplementary Fig. S2A). Aerobically, 30 µM 
CORM-3 was without effect on viability within 10 
min but caused a 10-fold reduction in counts after 
2 h. However, 125 µM CORM-3 reduced the 
viable count by 104-fold within 30 min; the 
marked increase in toxicity between 30 and 125 
µM CORM (Supplementary Fig. S2B) may reflect 
the level of accumulation of CORM-3 (see below).  
The toxicity of CORM-3, but not RuCl2(DMSO)4, 
to aerobic cells was also confirmed by fluorescent 
live/dead staining (Invitrogen): SYTO 9 stains all 
bacteria green, whereas propidium iodide 
penetrates only bacteria with damaged membranes 
and stains them red whilst reducing the amount of 
SYTO 9 when both are present. Aerobically, 
addition of CORM-3 caused a 48% reduction in 





increase in the percentage of dead and unhealthy 
cells (red or red/green) but, anaerobically, CORM-
3 did not reduce the percentage of live cells. 
RuCl2(DMSO)4 was without effect on the 
proportions of live and dead cells (data not 
shown). Thus, CORM-3 is a potent antibacterial 
molecule even under aerobic conditions. 
Uptake of CORM-3 by growing cells – To 
demonstrate uptake of CORM-3 by both aerobic 
and anaerobic cells, we assayed for the presence of 
Ru from the Ru(CO)3Cl(glycinate), since the 
radiolabelled compound is unavailable. Assays by 
ICP-AES of cells from CORM-3-treated cultures, 
after extensive washing and digestion to solubilize 
biomass, are presented in Table 1. The levels of 
Ru detected in control cells not treated with 
CORM-3 were insignificant as expected, since Ru 
has no known biological function. The majority of 
CORM-3 added was recovered in the culture 
supernatant and small amounts were found in the 
washings after treating cells with dilute HNO3. 
Although the absolute amounts of Ru recovered in 
digested cells was also small, these levels equated 
with significant intracellular concentrations 
assuming literature values (19) for the mass and 
volumes of individual cells. For aerobic cells, the 
estimated intracellular Ru concentration (209 µM) 
exceeds by 7-fold the concentration in the culture, 
whilst for anaerobic cells, the accumulation is 2.1-
fold. Recoveries in the procedure of over 80% 
testify to the reliability of the analytical data. In a 
further pair of experiments on aerobic cells, the 
recovery was lower (63%) but again a high level 
of intracellular uptake of Ru (168 µM) was 
demonstrated (results not shown). Thus, CORM-3 
(and  the CO released, 1 CO per CORM molecule) 
are taken up to achieve concentrations 
significantly greater than those in the external 
medium, and the capacity of aerobically grown 
cells to accumulate CORM-3 appears greater than 
for anaerobic cells, given the higher external 
CORM-3 concentrations used for the latter. Thus, 
in terms of intracellular uptake of Ru and the 
observed effects on cell viability (Supplementary 
Fig. S2), 30 µM CORM-3 for aerobic cells equates 
with 100 µM CORM for anaerobic cells. The 
uptake of Ru after treatment of aerobic cells with 
125 µM CORM was not investigated due to the 
extreme toxicity observed under these conditions. 
 CO is delivered intracellularly by CORM-
3 - Since CORM-3 is taken up by growing cells 
and is an effective inhibitor of growth at 
concentrations where dissolved CO gas is not, we 
investigated further CO delivery. The high affinity 
of ferrous sperm whale myoglobin for CO (kon/koff 
= 2 x 107 M-1) and the impermeability of bacterial 
cells to myoglobin (Mr 16.7 kDa) allows 
distinction between extracellular and intracellular 
CO. When CORM-3 and myoglobin at near 
equimolar concentrations were mixed in the 
absence of bacteria, there was immediate 
formation of the carbonmonoxy adduct, 
characterised by the appearance in CO difference 
spectra (reduced myoglobin + CO minus reduced 
myoglobin) (Fig. 1) of a Soret maximum at 426 
nm and minimum at 442 nm (29). In contrast, 
myoglobin addition to bacteria supplemented with 
CORM-3 detected reduced levels of CO; within 10 
min of CORM-3 addition to bacteria, only 28% of 
the initial CO was found by the myoglobin 
competition assay, and after 20 min only 15% 
(Fig. 1). Thus, in support of the ICP-AES assays, 
CORM-3 rapidly enters bacterial cells and renders 
CO inaccessible to exogenous myoglobin.  
 CORM-3 inhibits bacterial respiration 
and reacts with terminal oxidases - We next 
investigated the nature of the intracellular targets. 
Although CO is a classical inhibitor of respiration, 
high partial pressures of CO relative to O2 
(typically 9:1) are required for significant 
competitive inhibition (1). Surprisingly, CORM-3 
(125 or 250 µM) was an effective inhibitor of 
bacterial cell respiration when added to vigorously 
aerated cultures at concentrations equimolar with 
dissolved oxygen, i.e. approx 200 µM (Fig. 2A). 
Neither CO added as a gaseous solution nor 
RuCl2(DMSO)4 were effective as inhibitors under 
these conditions. Inhibition of respiration by 125 
µM CORM-3 was rapid, 50% inhibition being 
achieved within 10 min of CORM-3 addition (Fig. 
2B).  
Inhibition of respiration by CO was 
accompanied by rapid formation of carbonmonoxy 
adducts of terminal oxidases within intact cells 
when CORM-3 was added exogenously (Fig. 3). 
Immediately after CORM-3 addition to E. coli 
cells, the distinctive α-band at 648 nm of the CO 
compound of cytochrome d was formed, with 
accompanying change in the Soret region near 448 
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nm. Subsequently, the Soret features intensified 
and a trough formed at 560 nm, without change at 
648 nm, suggesting CO reactivity with a 
cytochrome of lower CO affinity. This component 
is probably the oxidase cytochrome bo' based on 
the appearance of the Soret band at 422 nm (the 
CO-ligated ferrous species) and a trough at 434 
nm (the loss of the ferrous signal) (29,30). In 
contrast, addition of a similar concentration of 
RuCl2(DMSO)4 did not result in reaction with 
cytochrome d over 60 min (Supplementary Fig. 
S3) but absorbance minima of lower magnitude 
centred at 432 and 562 nm indicated cytochrome 
oxidation perhaps due to the DMSO moiety of 
RuCl2(DMSO)4. We conclude that CORM-3, but 
not RuCl2(DMSO)4, or CO administered as a gas, 
is an effective respiratory inhibitor, an activity that 
is attributable to CO release and reaction with 
terminal oxidases.   
 CO delivered by CORM-3 elicits global 
transcriptional changes - To identify bacterial 
genes that are differentially expressed during 
exposure to CORM-3, we performed 
transcriptomic profiling of cultures exposed to 
CORM-3. In both aerobic and anaerobic cultures, 
the CORM-3 concentrations used (30 and 100 µM, 
respectively) were without significant effect on 
viability over 15 min (Supplementary Fig. S2) and 
growth rates were slowed to similar extents 
(Supplementary Fig. S1). The gene expression 
profiles were reproducible and revealed marked 
differences between the aerobic and anaerobic 
consequences of CORM-3 exposure (Figs. 4, 5). 
Microarray analysis is presented in full in 
Supplementary Tables S1-4. Under aerobic 
conditions, 63 genes were up-regulated by more 
than 2-fold (P<0.05) and 183 were down-regulated 
using the same criteria. Under anaerobic 
conditions, 29 genes were up-regulated by more 
than 2-fold (P<0.05) and 41 were down-regulated 
using the same criteria. The major functional 
categories of genes affected are described below. 
 CORM-3 targets bacterial respiration - In 
the defined medium used here, aerobic growth is 
dependent on respiratory energy conservation with 
oxygen as terminal electron acceptor. The effects 
of CO from CORM-3 on respiration (Fig. 2) and 
oxidases (Fig. 3) were reflected in dramatic down-
regulation of many genes encoding components of 
the aerobic respiratory chain (Fig. 4). Most 
prominent were 10- to 22-fold reductions in 
transcript levels for the entire cyo operon 
(cyoABCDE) that encodes the cytochrome bo’ 
heme-copper terminal oxidase and the sdh operon 
(sdhABCD) that encodes the membrane succinate 
dehydrogenase, which couples the Krebs cycle to 
the respiratory electron transport system. Down-
regulation of cyo genes was accompanied by 
modest up-regulation of the cydAB operon that 
encodes the alternative terminal oxidase, 
cytochrome bd. We also observed down-regulation 
of the nuo operon (11 genes) encoding the major 
NADH dehydrogenase, of fdo genes encoding 
three subunits of the membrane-bound formate 
dehydrogenase, and of glp genes encoding aerobic 
and anaerobic glycerol 3-phosphate 
dehydrogenases, and glycerol/glycerol 3-
phosphate transporters. There were smaller 
decreases in expression from genes in the atp 
operon (previously unc) encoding the F1Fo ATP 
synthase. 
 To confirm the differential regulation of 
oxidase genes revealed by transcriptome profiling, 
we first recorded absorbance difference spectra of 
intact cells from control and CORM-3-treated 
aerobic cultures of a cyo mutant, in which the sole 
CO-reactive oxidase is cytochrome bd. In reduced 
minus oxidised difference spectra, an elevated 
level of cytochrome d in the CORM-3-treated cells 
was evident from the characteristic red band at 633 
nm (Supplementary Fig. S4A). Interestingly, in 
CO difference spectra of this strain 
(Supplementary Fig. S4B), cytochrome d was 
readily detectable in control cells but not in 
cultures treated with CORM-3, a result that we 
attribute to reaction of the oxidase with CORM-
derived CO during growth, so that the baseline 
spectrum is not further perturbed by CO. These 
data confirm up-regulation of cytochrome bd by 
CORM-3 and reveal reaction of CORM-derived 
CO with the oxidase in vivo during growth. 
Second, we assayed cytochrome bo’ in wild-type 
cells by CO difference spectra using a spectral 
deconvolution method to eliminate cytochrome bd 
(Supplementary Fig. S4C). The distinctive Soret 
bands of cytochrome o (415, 429 nm) were 
detected in control, but not CO-RM-treated, cells. 
Third, we measured β-galactosidase activity in a 
Φ(cyo-lacZ) strain and demonstrated down-
regulation of cyo-lacZ activity by CORM-3, but 
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not by RuCl2(DMSO)4 (results not shown). 
Collectively, these data support a marked decrease 
in cyo operon transcription elicited by CORM-3 
and a modest up-regulation of the alternative 
oxidase, cytochrome bd (Fig. 4). 
 There was also evidence of a downshift in 
respiratory and bioenergetic gene expression 
anaerobically, also shown in Fig. 4. Under these 
conditions, fumarate is provided as alternative 
terminal electron acceptor. A much smaller set of 
genes was differentially regulated, but these 
included genes of the cyo and cyd operons, 
formate dehydrogenase, glycerol 3-phosphate 
dehydrogenase and succinate dehydrogenase. 
 CORM-3 perturbs metal biochemistry - In 
biology, CO binds preferentially and almost 
exclusively to transition metals, especially Fe(II) 
(2), but also cobalt (31,32). Transcriptomics 
revealed many genes known to be involved in 
metal metabolism, homeostasis or transport (Fig. 
5). Aerobically, CORM-3 elicited a 26-fold up-
regulation of spy, encoding a periplasmic protein 
that is induced by zinc and copper via the CpxR 
and BaeR sensor-response regulator systems (33).  
Other genes implicated in zinc homeostasis and 
regulation observed in this study are yodA (16-fold 
up-regulated) and znuA (5-fold up-regulated). The 
former encodes a periplasmic Zn- and Cd-binding 
protein (34-36). The znuA gene also encodes a 
periplasmic Zn(II)-binding protein (37,38) 
associated with the high-affinity ATP-binding 
cassette ZnuABC transporter (39). Genes encoding 
ferritin-like proteins were differentially regulated 
by CORM-3 in aerobically grown cells with ftnB 
being up-regulated and bfr down-regulated. 
Several genes in the membrane transport class are 
also implicated in metal homeostasis (see below). 
In anaerobically grown cells, spy was up-
regulated >100-fold and is thus the gene most 
dramatically regulated in response to CORM-3 
administration in our studies. Confirmation of the 
microarray data was obtained by measuring β-
galactosidase activity in anaerobic cultures of a 
strain harbouring a spy-lacZ transcriptional fusion; 
100 µM CORM-3 added to an exponentially 
growing culture elicited an increase from 381 to 
2960 Miller units over 60 min, whereas untreated 
cultures or those treated with 100 µM 
RuCl2(DMSO)4 showed no change 
(Supplementary Fig. S5). β-galactosidase was not 
measured at zero time, but the basal level is very 
low (< 36 Miller Units), similar to that measured 
for the untreated control at later times.  Addition 
of CuSO4 (200 mM) elicited only a 6-fold increase 
in spy transcription over 60 min (Supplementary 
Fig. S5), as reported recently (33).  
Other zinc-regulated genes exhibiting 
increased transcript levels on CORM-3 treatment 
were yodA and znuA (as in aerobic cells) but also 
zraP, encoding a periplasmic zinc-binding protein. 
We therefore considered whether CORM-3 
liberates free intracellular zinc. Zn was detectable 
in cell digests by ICP-AES at levels of 0.01-0.02 
µg per mg, but was not markedly affected on 
CORM-3 treatment of cells. Since these elemental 
analyses cannot distinguish between free and 
bound metal, we exploited the zinc-responsive 
expression of Φ(zntA-lacZ). This fusion is 
sensitive to intracellular zinc since zntA encodes a 
P-type ATPase that exports excess zinc and 
contributes to zinc homeostasis (40). We showed 
previously (24) that NO elicits intracellular zinc 
release that is detectable by this fusion and that the 
response is dependent on zinc sensing by zntR. In 
the absence of additional zinc in the medium, 
modest or insignificant changes in β-galactosidase 
activities were measured in both aerobic and 
anaerobic cultures treated with CORM-3   
(Supplementary Fig. S6). Therefore, to elevate 
expression of Φ(zntA-lacZ) from very low basal 
levels, zinc (0.5 mM) was added to cultures (24); 
under these conditions, significant increases in 
Φ(zntA-lacZ) expression were recorded 
(Supplementary Fig. S6). Thus, zinc release and 
metal homeostasis are  casualties of CORM-3 
treatment. 
 Differential expression of genes in other 
functional classes on CORM-3 treatment - 
Amongst the most dramatically down-regulated 
genes are several linked to acetate and acetyl 
group metabolism. Chief among these is acs, 
which was down-regulated 18-fold in aerobic 
cells. This gene encodes acetyl Co-A synthetase 
(ACS); intriguingly, this metalloenzyme, together 
with CO dehydrogenase (CODH), plays a pivotal 
role in CO metabolism (41). CODH oxidizes CO 
to CO2, providing low-potential electrons for the 
cell, or alternatively reduces CO2 to CO. The latter 
reaction, when coupled to ACS, generates acetyl-
CoA from CO2 for cell carbon synthesis. Also 
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highly down-regulated were the acetate transporter 
gene actP (11-fold), and three genes in the ace 
operon (anaerobically) encoding isocitrate lyase, 
malate synthase and pyruvate dehydrogenase. 
Genes implicated in diverse membrane transport 
processes were strongly represented in the aerobic 
gene lists (Supplementary Tables S1-2). Notable 
are the down-regulated genes encoding 
transporters for methyl-galactoside (mglABC), and 
the highly up-regulated (8- to 13-fold) mdtABC 
operon implicated in a multidrug export system, 
which is also up-regulated in response to 
supraoptimal zinc levels (17). The cus operon was 
highly up-regulated anaerobically and this too is 
up-regulated in response to high zinc levels (17).  
 Statistical analysis of CO-RM data - In 
modelling the transcriptome data, we focused on a 
subset of eight key regulators: ArcA, CRP, Fis, 
FNR, Fur, BaeR, CpxR and IHF. A list of genes 
populating the (overlapping) regulons of these 
transcription factors, together with information on 
the sign of the regulation where available, was 
obtained from regulonDB 
(http://regulondb.ccg.unam.mx/). The estimated 
change in transcription factor activity (with 
associated uncertainty) for these regulators is 
shown in Fig. 6. In aerobic conditions, all 
transcription factors investigated exhibit a 
significant change in activity after 15 min 
exposure to CORM-3. In all cases, the signal to 
noise ratio is very high, giving estimated p-values 
of less than 10-6. Interestingly, the reaction of the 
transcriptional regulators in anaerobic conditions 
seems to be very different. In particular, no 
significant change in activity was predicted for 
CRP, Fis and FNR under anaerobic conditions. In 
order to assess the statistical significance of these 
results, we ran the model on the same 
transcriptomic data, but reshuffling at random the 
regulatory network. This was repeated for 100 
different random reshuffles. Strikingly, in the vast 
majority of cases (84%), the model identified only 
one significantly changing regulator in these 
random networks; in 12 cases it explained the data 
with two significantly changing regulators, and in 
only 4 cases it predicted three regulators to 
significantly change. Based on these simulations, 
we can estimate that the probability of obtaining 
such a rich regulatory response purely from 
random data is less than 10-6. 
 
DISCUSSION 
 CO is a classical respiratory poison but 
also a critical endogenous 'gasotransmitter' (42, 
43). Its potential impact in microbiology is 
considerable: contrary to expectations that 
endogenously generated CO might suppress the 
inflammatory response, HO-derived or CO-RM-
derived CO limits sepsis (11), suggesting new 
intervention approaches in microbial pathogenesis 
and disease. Although CO is also toxic in vitro to 
gram-positive and -negative bacteria (12), the 
mode of action has remained obscure. It is 
remarkable that, in the present study, CORM-3 is 
effective as an antimicrobial agent (whether 
assayed by growth rates or viability counts or 
live/dead staining) even under aerobic conditions, 
and at ambient oxygen concentrations higher than 
CO. Critically, the control molecule 
RuCl2(DMSO)4  is ineffective as an inhibitor of 
growth or respiration, and does not elicit increased 
spy gene expression, suggesting that the effects 
observed here can be directly attributed to released 
CO. Based on (i) direct assays of the accumulation 
in cells of Ru from Ru(CO)3Cl(glycinate) 
(CORM-3) by bacteria (Table 1), (ii) our use of 
myoglobin to demonstrate loss of accessible CO 
from the culture media (Fig. 1) and (iii) direct 
demonstration of the formation of the 
carbonmonoxy forms of terminal oxidases (Fig. 3), 
we propose that CORM-3 effectively delivers CO 
to intracellular targets. We are unaware of other 
reports of the accumulation of a Ru-containing 
CO-RM by bacterial or higher cells, but Mo is 
accumulated by bacteria after administration of the 
CO-RM tetraethylammonium Mo pentacarbonyl 
bromide (ALF062) (12). It should be noted that 
although only 1 CO is promptly released from 
CORM-3, 2 residual CO moieties remain 
coordinated to the Ru. Intracellular catabolism 
may result in release of >1 CO per CORM-3. 
Toxicity of CORM-3 is observed even in 
competition with oxygen, perhaps effecting a rise 
in the CO/O2 ratio in critical micro-environments 
of the cell, membrane or oxidase active site. The 
importance of respiration as a target for CO-RMs 
is highlighted by the recent report that CORM-2 or 
CO gas inhibits L-type Ca2+ channels in rat 
ventricular cardiac myocytes (44). The inhibition 
can be attributed to inhibition by CO of electron 
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transfer to cytochrome c oxidase, consequent 
generation of reactive oxygen species, and redox 
modulation of critical cysteine residues in the 
channel. Although the idea that regulatory effects 
might be due in part to part-reduced oxygen 
species appears inconsistent with the presented 
modelling outcome, Sox has been implicated in 
additional preliminary modelling (G. Sanguinetti, 
unpublished) which requires extension in a time-
course study. Critically, direct experimental assays 
of superoxide and peroxide generation are required 
to test further this hypothesis but are outside the 
scope of the present report. 
 Transcriptomics and modelling reveal the 
involvement of several CO-RM-responsive 
transcription factors, but the mechanism for only 
one of these, ArcAB, can be readily explained 
with current information. This two-component 
signal transduction system of E. coli mediates 
adaptive responses to the prevailing respiratory 
conditions. Oxidised forms of ubiquinone in the 
cytoplasmic membrane act as direct negative 
signals that inhibit autophosphorylation of ArcB 
and consequently of formation of ArcA-P (45), 
which binds to DNA targets. Thus, inhibition of 
respiration by CO, for example, results in 
ubiquinone reduction; under these conditions, the 
kinase activity of ArcB is unchecked, the level of 
ArcA-P rises and repression of respiratory chain 
gene expression ensues. The widespread 
occurrence of the ArcAB system in diverse 
bacteria, including Salmonella, Vibrio, Shigella, 
Yersinia and Erwinia (46) suggests that pathogens 
might sense host-derived CO by such a 
mechanism. 
 The involvement of CRP activity in 
aerobic cells, revealed in the transcriptomics and 
their mathematical modelling, may be a 
consequence of changing cAMP availability, in 
turn driven by the effects of CO on DOSEc, a 
heme-regulated phosphodiesterase that is 
expressed especially in aerobic cells (47). It is well 
known that CO combines only with ferrous, not 
ferric, heme (1) but interaction of CO with other 
intracellular metal targets might explain the 
participation in the cellular responses to CORM-3 
of Fnr and Fur, both of which contain Fe centers. 
Fnr contains, in its active form, a [4Fe-4S] cluster 
that is reactive with O2 (48) and NO (49). 
Although hydrogenases and nitrogenases 
possessing [4Fe-4S] clusters are inhibited by CO, 
rapid interaction of a synthetic cluster with CO 
occurred only when the highly reduced state is 
accessed, corresponding to a physiologically 
unusual reduction level (50). Future work might 
test Fnr in vitro with CO-RMs. A less likely 
explanation is that ferrous iron binds to, say two 
cysteine and two lysine residues, and CO then 
binds to iron (51). Even bleomycin will coordinate 
Fe(II), which then coordinates CO, but the binding 
is weak (52). We are unaware of any reports on 
the reactivity of CO with the metal centers of Fur. 
Other effects may reflect not CO reactivity 
in vivo but global disturbance by the ruthenium 
content of CORM-3. Previous work has shown the 
effects of dimeric, mixed-valence Ru compounds 
(53) on growth of E. coli at micromolar 
concentrations, but ruthenium nitrosyl complexes 
are less inhibitory because of their inability to 
enter cells (54). The effects of CORM-3 on 
intracellular free (but not total) zinc pools cannot 
currently be explained. 
The up-regulation of ferritin-like proteins 
is of interest since FtnB in Salmonella is 
implicated in repair of oxidatively damaged 
proteins (55), which could arise from inhibition by 
CO of terminal respiratory pathways and 
consequent radical formation. Indeed, CORM-2 
increases oxidant production by mitochondria (56) 
and NO, by arresting respiration of Salmonella, 
triggers an adaptive response to oxidative stress 
(57). 
 Also implicated both aerobically and 
anaerobically by the modelling data are CpxR and 
BaeR. The Cpx stress response is activated by 
misfolded envelope proteins and, in the present 
study, cpxP (encoding the periplasmic inhibitor) is 
highly up-regulated both aerobically (24-fold; 
Supplementary Table S2) and anaerobically (8-
fold; Supplementary Table S4), suggesting that the 
Cpx response is important in maintaining the 
integrity of envelope proteins in the face of CO-
related insults. The most dramatic up-regulation in 
this study is that of spy, which encodes a 
periplasmic protein of obscure function, inducible 
by exposure to copper and zinc ions (33) and by 
envelope stress in general (58). The spy gene is 
regulated by both BaeSR and CpxAR (33,58).  
 In conclusion, we demonstrate the 
effectiveness of a ruthenium-based carbonyl 
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compound as an inhibitor of bacterial growth and 
respiration and the rapid uptake of this compound 
into bacterial cells where heme proteins are 
targeted. Moreover, the effects on growth and 
viability are evident in aerobic cultures, in 
apparent contradiction to the conventional view 
that CO acts by competing with oxygen for 
binding to ferrous heme proteins. Understanding 
the delivery of CO-RMs and/or CO release to 
intracellular targets, some of which are revealed 
by global transcript profiling, will be critical for 
future antimicrobial applications of CO-RMs. 
Although physiological side-effects of the rapid 
release of CO (as measured by formation of 
carbonmonoxymyoglobin in vitro) might be 
anticipated, increases in the levels of the CO 
adduct of hemoglobin in vivo are modest. Thus, 
intravenous injections of CORM-3 in mice do not 
lead to substantial increases in 
carbonmonoxyhemoglobin (0.5% increase per 100 
µM CORM-3) (59). Since the first symptoms of 
CO poisoning in humans (headache, dilation of 
cutaneous blood vessels) is manifest at 
carbonmonoxyhemoglobin concentrations 
exceeding 15-20%, there is reason to predict that 
side-effects of CO-RM therapy may be minimal.  
Surprisingly, the predominantly aerobic 
environment of the vasculature and macrophage 
may prove to be a suitable milieu for antimicrobial 
CO-RM activity.  
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Uptake of CORM-3 by aerobically and anaerobically growing E. coli 
CORM-3 was added to aerobic (final concentration 30 µM) and anaerobic (final concentration 100 µM) 
cultures. Cells recovered by centrifugation were subjected to successive washings as detailed in 
Experimental Procedures. Ru was assayed in all fractions including the culture supernatant and acid-
digested cell pellet by ICP-AES then used to calculate intracellular Ru concentrations, using the values 
for cell dry mass and volume detailed in Experimental Procedures. The values are means of two 
biological replicates (growths) for each condition, and each sample was assayed in triplicate by ICP-AES. 
 Ru (µg) 













Aerobic 26.4 19.4 0.067 0.40 209 81.0 
Anaerobic 85.9 63.2 0.72 0.28 214 80.7 
1Only given where determinations exceed limits of detection (LOD) 
2Ru levels in control cells were less than the LOD, defined as 3x s.d. of a blank sample 
3Expressed as the sum of Ru assayed in the culture supernatant, washes and cell pellet as a percentage of 
the added Ru in the form of CORM-3
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FIGURE 1. Myoglobin competition assays reveal CORM-3 uptake by bacteria. CORM-3 (8 µM) and 
myoglobin (10 µM) were added to buffer only (A) or buffer plus cells (B). CORM-3 was added at t = 0, 
and myoglobin added at 0 (−), 10 (− −), or 20 min (- - -). Difference absorbance spectra are shown: the 
reference spectrum is Fe(II) myoglobin with cells or buffer, reduced with dithionite.  
 
FIGURE 2. CORM-3 inhibits bacterial aerobic respiration. In A, cultures were grown to mid-log 
phase, then exposed for 2 h to 125 or 250 µM CORM-3 (black bars), RuCl2(DMSO)4 (dark hatched) or 
CO gas-saturated solution (light hatched); controls (no addition) are shown by white bars. Protein 
concentration of the suspensions was 4.5 mg ml-1. Asterisks denote significant differences from control: 
*, P<0.01, **, P<0.002, ***, P<0.001. B shows the time course of inhibition by 125 µM CORM-3 of cell 
respiration (2.6 mg protein ml-1).  
 
FIGURE 3. Reaction of terminal oxidases in vivo with CORM-3 (2 mM) added to intact cells in a 
dual wavelength spectrophotometer. CO difference spectra (reduced + CO minus reduced) were taken 
at times (shown in min) after addition of CORM-3.  
 
FIGURE 4. Differential expression of genes involved in respiratory electron transfer and energy 
conservation. The mean fold increase or decrease in individual gene expression after exposure to 
CORM-3 compared to controls lacking the compound both aerobically (30 µM CORM-3) and 
anaerobically (100 µM CORM-3) is indicated by the colour scale bar. Genes encoding terminal oxidases 
are highlighted in pale grey; genes encoding dehydrogenases are highlighted in darker grey. Relevant 
regulatory proteins were taken from the EcoCyc and EchoBase websites. SU = subunit. 
 
FIGURE 5. Differential expression of genes involved in metal biochemistry. The mean fold increase 
or decrease in individual gene expression after exposure to CORM-3 compared to controls lacking the 
compound both aerobically (30 µM CORM-3) and anaerobically (100 µM CORM-3) is indicated by the 
colour scale bar. Genes implicated in metabolism of, or regulation by, zinc ions are highlighted in pale 
grey. Relevant regulatory proteins were taken from the EcoCyc and EchoBase websites. SU = subunit. 
 
FIGURE 6. Probabilistic modelling of the transcriptomic data for the effects of CORM-3 treatment. 
Predicted activities (which may be positive or negative) under aerobic (black) and anaerobic (grey) 
conditions are shown for ArcA, CRP, Fis, FNR, Fur, BaeR, CpxR and IHF. CORM-3 concentrations were 
30 µM (aerobic) and 100 µM (anaerobic). 
 
 
 
 
 
 
